Regeneron Pharmaceuticals Inc. buy BMO Capital Markets
Start price
04.08.25
/
50%
€494.10
Target price
04.08.26
€552.90
Performance (%)
33.57%
Price
22:26
€658.20
Summary
This prediction is currently active. The BUY prediction by BMO_Capital_Markets for Regeneron Pharmaceuticals Inc. has seen massive gains of 33.57%. Dividends of €1.76 are taken into consideration when calculating the performance. This prediction currently runs until 04.08.26. The prediction end date can be changed by BMO_Capital_Markets at any time. BMO_Capital_Markets has 50% into this predictionRegeneron Pharmaceuticals, Inc. is a biotechnology company that is engaged in the discovery, development, and commercialization of medicines for the treatment of serious medical conditions. The company's products include EYLEA, a treatment for wet age-related macular degeneration and diabetic macular edema; Dupixent, a treatment for atopic dermatitis and asthma; and Libtayo, a treatment for certain types of cancer. Regeneron also has a strong focus on research and development, with a pipeline of potential new treatments for a variety of diseases. The company is headquartered in Tarrytown, New York and trades on the NASDAQ stock exchange under the symbol REGN.
Performance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Regeneron Pharmaceuticals Inc. | 3.320% | 3.320% |
| iShares Core DAX® | 3.002% | 3.742% |
| iShares Nasdaq 100 | 2.966% | 1.308% |
| iShares Nikkei 225® | 5.606% | 4.472% |
| iShares S&P 500 | 2.312% | 1.880% |
Comments by BMO_Capital_Markets for this prediction
In the thread Regeneron Pharmaceuticals Inc. diskutieren
Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) had its price target raised by analysts at BMO Capital Markets from $600.00 to $640.00. They now have an "outperform" rating on the stock.
Ratings data for REGN provided by MarketBeat
Stopped prediction by BMO_Capital_Markets for Regeneron Pharmaceuticals Inc.
Regeneron Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€625.20
04.12.25
04.12.25
€728.79
04.12.26
04.12.26
5.28%
22:26
22:26
Regeneron Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€427.60
02.06.25
02.06.25
€527.70
02.06.26
02.06.26
54.34%
22:26
22:26
Regeneron Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€515.60
30.04.25
30.04.25
€703.60
30.04.26
30.04.26
28.17%
22:26
22:26
Regeneron Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€681.40
04.02.25
04.02.25
€869.77
04.02.26
04.02.26
-2.89%
22:26
22:26
Regeneron Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€779.00
01.11.24
01.11.24
€1,096.8
01.11.25
01.11.25
-27.09%
02.11.25
02.11.25
Regeneron Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€939.20
24.09.24
24.09.24
€1,165.3
24.09.25
24.09.25
-47.87%
25.09.25
25.09.25
Regeneron Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€858.00
05.02.24
05.02.24
€1,006.8
05.02.25
05.02.25
-19.14%
06.02.25
06.02.25